DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Meperidine hydrochlorideis the generic ingredient in four branded drugs marketed by Hospira, Us Pharm Holdings, Abbott, Baxter Hlthcare, Igi Labs Inc, Intl Medication, Parke Davis, Watson Labs, West-ward Pharms Int, Icu Medical Inc, Specgx Llc, Hikma, Anda Repository, Barr, Duramed Pharms Barr, Epic Pharma, Sun Pharm Inds Inc, Sun Pharm Industries, Vintage Pharms, and Wyeth Ayerst, and is included in forty-five NDAs. Additional information is available in the individual branded drug profile pages.
There are six drug master file entries for meperidine hydrochloride. Six suppliers are listed for this compound.
Recent Clinical Trials for meperidine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|Makassed General Hospital||N/A|
|University of Washington||Phase 4|
Pharmacology for meperidine hydrochloride
|Drug Class||Opioid Agonist |
|Mechanism of Action||Full Opioid Agonists |
Medical Subject Heading (MeSH) Categories for meperidine hydrochloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Barr||MEPERIDINE HYDROCHLORIDE||meperidine hydrochloride||TABLET;ORAL||088639-001||Jul 2, 1984||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|West-ward Pharms Int||MEPERIDINE HYDROCHLORIDE||meperidine hydrochloride||INJECTABLE;INJECTION||080445-004||Approved Prior to Jan 1, 1982||AP||RX||No||No||Start Trial||Start Trial||Start Trial|
|Us Pharm Holdings||DEMEROL||meperidine hydrochloride||TABLET;ORAL||005010-004||Approved Prior to Jan 1, 1982||DISCN||Yes||No||Start Trial||Start Trial||Start Trial|
|Igi Labs Inc||MEPERIDINE HYDROCHLORIDE||meperidine hydrochloride||INJECTABLE;INJECTION||089783-001||Mar 31, 1989||DISCN||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.